Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers

AAPS PharmSciTech

Volumn 4, Issue 3, 2003, Pages

  Smyth, Hugh D C ^a   Hickey, Anthony J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Atomization; Cascade impaction; HFA 134a; Laser diffraction; Metered dose inhaler; Particle size distribution

Indexed keywords

ALCOHOL; NORFLURANE; PROPELLANT; RHODAMINE B; FLUORINATED HYDROCARBON;

AEROSOL; ARTICLE; CHEMICAL ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUTION; EVAPORATION; IN VITRO STUDY; LASER DIFFRACTION; MATHEMATICAL COMPUTING; MEASUREMENT; METERED DOSE INHALER; PARTICLE SIZE; TIME; VAPOR PRESSURE; CHEMISTRY; COMPARATIVE STUDY; EQUIPMENT DESIGN; LASER; METABOLISM; METHODOLOGY; PHARMACEUTICS; STANDARD; STATISTICAL DISTRIBUTION; STATISTICS;

AEROSOLS; CHEMISTRY, PHARMACEUTICAL; EQUIPMENT DESIGN; ETHANOL; HYDROCARBONS, FLUORINATED; LASERS; METERED DOSE INHALERS; PARTICLE SIZE; STATISTICAL DISTRIBUTIONS; TECHNOLOGY, PHARMACEUTICAL;

EID: 23144453911     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt040338     Document Type: Article

References (28)

1. Alexander DJ. Safety of propellants. J Aerosol Med. 1995;8(suppl 1):S29-34.
2. Vervaet C, Byron PR. Drug-surfactant-propellant interactions in HFA-formulations. Int J Pharm. 1999;186(1):13-30.
3. Blondino FE, Byron PR. Surfactant dissolution and water solubilization in chlorine-free liquified gas propellants. Drug Dev Ind Pharm. 1998;24(10):935-945.
4. Smith IJ. The challenge of reformulation. J Aerosol Med. 1995;8(suppl 1):S19-27.
5. Warren SJ, Farr SJ. Formulation of solution metered dose inhalers and comparison with aerosols emitted from conventional suspension systems. Int J Pharm. 1995;124:195-203.
6. Seale JP, Harrison LI. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics. Respir Med. 1998;92(suppl A):9-15.
7. Leach C. Effect of formulation parameters on hydrofluoroal-kane-beclomethasone dipropionate drug deposition in humans. J Allergy Clin Immunol. 1999;104(6):S250-252.
8. Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest. 2002;122(2):510-516.
9. Dunbar CA, Watkins AP, Miller JF. An experimental investigation of the spray issued from a pMDI using laser diagnostic techniques. J Aerosol Med. 1997;10(4):351-368.
10. Cheng YS, Fu CS, Yazzie D, Zhou Y. Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica. J Aerosol Med. 2001;14(2):255-266.
11. Polli GP, Grim WM, Bacher FA, Yunker MH. Influence of formulation on aerosol particle size. J Pharm Sci. 1969;58:484-486.
12. Williams RO, Liu J. Influence of formulation additives on the vapor pressure of hydrofluoroalkane propellants. Int J Pharm. 1998;166:99-103.
13. Tzou T-Z. Density, excess molar volume, and vapor pressure of propellant mixtures in metered-dose inhalers: deviation from ideal mixtures. In: Dalby RN, Byron PR, Farr SJ, eds. Respiratory Drug Delivery VI. Buffalo Grove, IL: Interpharm Press, Inc; 1998:439-443.
14. Martin A. Physical Pharmacy. 4th ed. Philadephia, PA: Lippincott Williams & Wilkins; 1993.
15. Smyth HDC, Hickey AJ. Comparative particle size analysis of solution propellant driven metered dose inhalers using cascade impaction and laser diffraction. In: Dalby RN, Byron PR, Farr SJ, Peart J, eds. Respiratory Drug Delivery VIII. Raleigh, NC: DHI Publishing; 2002:731-734.
16. United States Pharmacopeia. USP24/NF19. General chapter <601> Aerosols. In: United States Pharmacopeia. Rockville, MD: United States Pharmacopeia; 1999:1895.
17. Ranucci J. Dynamic plume-particle size analysis using laser diffraction. Pharm Tech. 1992;16:108, 110, 112, 114.
18. Newman SP. Use of gamma scintigraphy to evaluate the performance of new inhalers. J Aerosol Med. 1999;12(suppl 1):S25-31.
19. Clark AR. Metered Atomization for Respiratory Drug Delivery [dissertation]. Leicestershire, UK: Loughborough University of Technology; 1991.
20. Dunbar CA, Watkins AP, Miller JF. Theoretical investigation of the spray from a pressurized metered-dose inhaler. Atomization Sprays. 1997;7(4):417-436.
21. Finlay WH. The Mechanics of Inhaled Pharmaceutical Aerosols. London, UK: Academic Press; 2001.
22. Holzner PM, Mueller BW. Particle size determination of metered-dose inhalers by laser diffraction, cascade impaction and liquid impingement. Paper Presented at 1st World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Budapest, 1995:765-766.
23. de Boer AH, Gjaltema D, Hagedoorn P, Frijlink HW. Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique. Int J Pharm. 2002;249(1-2):219-231.
24. Everard ML. CFC transition: the emperor's new clothes. Each class of drug deserves a delivery system that meets its own requirements. Thorax. 2000;55:811-814.
25. Leach C. Enhanced drug delivery through reformulating MDIs with HFA propellants: drug deposition and its effect on preclinical and clinical programs. In: Dalby RN, Byron PR, Farr SJ, eds. Respiratory Drug Delivery V. Buffalo Grove, IL: Interpharm Press, Inc; 1996:133-144.
26. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J. 1998;12(6):1346-1353.
27. Lefebvre AH. Atomization and Sprays. London, UK: Taylor & Francis; 1989.
28. Faeth GM, Hsiang LP, Wu PK. Structure and breakup properties of sprays. Int J Multiphase Flow. 1995;21(suppl):99-127.